title: Microbes bind complement inhibitor factor H via a common site.
abstract: To cause infections microbes need to evade host defense systems, one of these being the evolutionarily old and important arm of innate immunity, the alternative pathway of complement. It can attack all kinds of targets and is tightly controlled in plasma and on host cells by plasma complement regulator factor H (FH). FH binds simultaneously to host cell surface structures such as heparin or glycosaminoglycans via domain 20 and to the main complement opsonin C3b via domain 19. Many pathogenic microbes protect themselves from complement by recruiting host FH. We analyzed how and why different microbes bind FH via domains 19-20 (FH19-20). We used a selection of FH19-20 point mutants to reveal the binding sites of several microbial proteins and whole microbes (Haemophilus influenzae, Bordetella pertussis, Pseudomonas aeruginosa, Streptococcus pneumonia, Candida albicans, Borrelia burgdorferi, and Borrelia hermsii). We show that all studied microbes use the same binding region located on one side of domain 20. Binding of FH to the microbial proteins was inhibited with heparin showing that the common microbial binding site overlaps with the heparin site needed for efficient binding of FH to host cells. Surprisingly, the microbial proteins enhanced binding of FH19-20 to C3b and down-regulation of complement activation. We show that this is caused by formation of a tripartite complex between the microbial protein, FH, and C3b. In this study we reveal that seven microbes representing different phyla utilize a common binding site on the domain 20 of FH for complement evasion. Binding via this site not only mimics the glycosaminoglycans of the host cells, but also enhances function of FH on the microbial surfaces via the novel mechanism of tripartite complex formation. This is a unique example of convergent evolution resulting in enhanced immune evasion of important pathogens via utilization of a "superevasion site."
authors: Haartman Institute, Department of Bacteriology and Immunology and Immunobiology Research Program, University of Helsinki, Helsinki, Finland. taru.meri@helsinki.fi
authors: T
authors: T
authors: Meri
authors: H
authors: H
authors: Amdahl
authors: M J
authors: MJ
authors: Lehtinen
authors: S
authors: S
authors: Hyvärinen
authors: J V
authors: JV
authors: McDowell
authors: A
authors: A
authors: Bhattacharjee
authors: S
authors: S
authors: Meri
authors: R
authors: R
authors: Marconi
authors: A
authors: A
authors: Goldman
authors: T S
authors: TS
authors: Jokiranta
mesh_terms: D001419:Bacteria / Q000235:genetics / Q000276:immunology / Q000378:metabolism* / Q000472:pathogenicity; D001665:Binding Sites; D001886:Bordetella pertussis / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity; D001898:Borrelia / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity; D002176:Candida albicans / Q000235:genetics / Q000276:immunology / Q000378:metabolism* / Q000472:pathogenicity; D002462:Cell Membrane / Q000378:metabolism; D003167:Complement Activation; D017242:Complement Factor H / Q000737:chemistry / Q000378:metabolism*; D006193:Haemophilus influenzae / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity; D006801:Humans; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011550:Pseudomonas aeruginosa / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity; D013211:Staphylococcus aureus / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity; D013296:Streptococcus pneumoniae / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity
chemical_list: D017242:Complement Factor H
references: Mol Immunol. 2007 Sep;44(16):3889-900
references: 17768107
references: J Biol Chem. 1991 Jan 5;266(1):399-405
references: 1985908
references: Nat Struct Mol Biol. 2011 Apr;18(4):463-70
references: 21317894
references: J Bacteriol. 2004 May;186(9):2612-8
references: 15090501
references: Mol Immunol. 2007 Sep;44(16):3850-7
references: 17768102
references: J Immunol. 2006 Jul 1;177(1):501-10
references: 16785547
references: J Immunol. 2002 Nov 1;169(9):4702-6
references: 12391176
references: Infect Immun. 2006 Apr;74(4):2007-14
references: 16552029
references: Nature. 2009 Apr 16;458(7240):890-3
references: 19225461
references: Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268-72
references: 1067618
references: Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20
references: 276881
references: J Biol Chem. 2004 Jan 23;279(4):2421-9
references: 14607842
references: J Immunol. 2007 May 1;178(9):5848-58
references: 17442969
references: Science. 2005 Apr 15;308(5720):419-21
references: 15761120
references: J Immunol. 2012 Jan 1;188(1):426-35
references: 22140259
references: Nature. 2006 Nov 9;444(7116):213-6
references: 17051160
references: J Immunol. 2009 Jun 1;182(11):7009-18
references: 19454698
references: Mol Immunol. 2010 Aug;47(13):2187-97
references: 20580090
references: Infect Immun. 2006 Aug;74(8):4519-29
references: 16861638
references: J Immunol. 1995 Jul 1;155(1):348-56
references: 7541419
references: EMBO J. 2006 Apr 19;25(8):1784-94
references: 16601698
references: Curr Opin Microbiol. 2012 Feb;15(1):92-9
references: 22088393
references: J Immunol. 2008 Jul 1;181(1):537-45
references: 18566420
references: Mol Immunol. 2010 May;47(9):1686-91
references: 20378178
references: Mol Immunol. 1999 Mar-Apr;36(4-5):241-8
references: 10403477
references: Infect Immun. 2002 Sep;70(9):5185-92
references: 12183569
references: Mol Immunol. 2011 Jan;48(4):697-705
references: 21167605
references: J Biol Chem. 2009 Jun 5;284(23):15650-8
references: 19351878
references: Mol Immunol. 2009 May;46(8-9):1860-6
references: 19303642
references: Nat Rev Microbiol. 2008 Feb;6(2):132-42
references: 18197169
references: J Immunol. 2007 Sep 1;179(5):2979-88
references: 17709513
references: J Exp Med. 1976 Nov 2;144(5):1147-63
references: 62817
references: J Immunol. 2012 Oct 1;189(7):3528-37
references: 22922817
references: Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2897-902
references: 21285368
references: Am J Pathol. 2005 Oct;167(4):1173-81
references: 16192651
references: Complement Inflamm. 1989;6(4):270-80
references: 2527715
references: Nat Immunol. 2009 Jul;10(7):728-33
references: 19503104
references: Infect Immun. 1998 Apr;66(4):1427-31
references: 9529063
references: J Immunol. 1995 Dec 15;155(12):5663-70
references: 7499851
references: Science. 2005 Apr 15;308(5720):421-4
references: 15761121
references: J Immunol. 1998 Apr 1;160(7):3342-8
references: 9531293
references: Proc Natl Acad Sci U S A. 1990 May;87(10):3982-6
references: 1692629
references: J Biol Chem. 2001 Mar 16;276(11):8427-35
references: 11113124
references: J Biol Chem. 2007 Jun 29;282(26):18960-8
references: 17360715